Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.2520 EUR
−14.77 M EUR
36.12 M EUR
24.87 M
About KUROS N
Sector
Industry
CEO
Christopher T. Fair
Website
Headquarters
Schlieren
Founded
2000
ISIN
CH0325814116
FIGI
BBG000FG66R8
Kuros Biosciences Ltd. operates as biopharmaceutical company, which engages in developing products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals, and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment offers Fibrin-PTH, a drug-biologic combination which promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and by increasing the lifespan of bone-forming cells. The Legacy portfolio segment is involved in all other products that do not belong to the group's core business strategy. The company was founded by Didier Cowling in 2000 and is headquartered in Schlieren, Switzerland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on MUN exchange KUROS BIOSCI.AG NAM.SF-,1 stocks are traded under the ticker YTSN.
We've gathered analysts' opinions on KUROS BIOSCI.AG NAM.SF-,1 future price: according to them, YTSN price has a max estimate of 20.30 EUR and a min estimate of 20.30 EUR. Watch YTSN chart and read a more detailed KUROS BIOSCI.AG NAM.SF-,1 stock forecast: see what analysts think of KUROS BIOSCI.AG NAM.SF-,1 and suggest that you do with its stocks.
YTSN reached its all-time high on Jun 24, 2016 with the price of 21.4086 EUR, and its all-time low was 1.4736 EUR and was reached on Jan 30, 2019. View more price dynamics on YTSN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track KUROS BIOSCI.AG NAM.SF-,1 financials in yearly and quarterly reports right on TradingView.
KUROS BIOSCI.AG NAM.SF-,1 is going to release the next earnings report on Mar 12, 2025. Keep track of upcoming events with our Earnings Calendar.
KUROS BIOSCI.AG NAM.SF-,1 revenue for the last half-year amounts to 33.02 M EUR, despite the estimated figure of 31.15 M EUR. In the next half-year revenue is expected to reach 48.76 M EUR.
YTSN net income for the last half-year is −219.11 K EUR, while the previous report showed −9.34 M EUR of net income which accounts for 97.65% change. Track more KUROS BIOSCI.AG NAM.SF-,1 financial stats to get the full picture.
No, YTSN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 25, 2024, the company has 5.00 employees. See our rating of the largest employees — is KUROS BIOSCI.AG NAM.SF-,1 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KUROS BIOSCI.AG NAM.SF-,1 EBITDA is −2.39 M EUR, and current EBITDA margin is −18.33%. See more stats in KUROS BIOSCI.AG NAM.SF-,1 financial statements.
Like other stocks, YTSN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KUROS BIOSCI.AG NAM.SF-,1 stock right from TradingView charts — choose your broker and connect to your account.